Global Cancer Monoclonal Antibodies Market Trends And Strategies Of Major Players In The Cancer Monoclonal Antibodies Market 2020
4 Nov, 2020
The global cancer monoclonal antibodies market is expected to decline from $48.36 billion in 2019 to $45.40 billion in 2020 at a compound annual growth rate (CAGR) of -6.13%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $61.15 billion in 2023 at a CAGR of 10.44%.
The cancer monoclonal antibodies market consists of sales of monoclonal antibodies used for the treatment of cancer and related services by entities (organizations, sole traders and partnerships) that produce monoclonal antibodies for cancer treatment. Monoclonal antibodies are highly specific molecules for cancer cells as they bind to the proteins on their surface and it activates an immune response. The market consists of revenue generated by cancer monoclonal antibodies companies manufacturing cancer monoclonal antibodies drugs.
Request For A Sample For The Global Cancer Monoclonal Antibodies Market Report:
The global cancer monoclonal antibodies market is further segmented based on type and geography.
By Monoclonal Antibody Therapies: Bevacizumab (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), Others.
By Application: Breast Cancer, Blood Cancer, Liver Cancer, Brain Cancer, Colorectal Cancer, Others.
By Geography: The global cancer monoclonal antibodies market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North America cancer monoclonal antibodies market accounts for the largest share in the global cancer monoclonal antibodies market.
Read More On The Report For The Global Cancer Monoclonal Antibodies Market At:
Trends In The Cancer Monoclonal Antibodies Market
Companies in the cancer monoclonal antibodies market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated with each other as well as academic and research institutions in this market by way of partnerships and in- or out-licensing deals, this trend has been increasing over recent years.
Cancer Monoclonal Antibodies Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides cancer monoclonal antibodies market overviews, analyzes and forecasts market size and growth for the global cancer monoclonal antibodies market, cancer monoclonal antibodies market share, cancer monoclonal antibodies market players, cancer monoclonal antibodies market segments and geographies, cancer monoclonal antibodies market’s leading competitors’ revenues, profiles and market shares. The cancer monoclonal antibodies market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.